Surgical Management of Zollinger-Ellison Syndrome; State of the Art

Surgical Clinics of North America

Volumn 89, Issue 5, 2009, Pages 1091-1103

  Morrow, Ellen H ^a   Norton, Jeffrey A ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Diagnosis; Gastrinoma; Localization; MEN 1; Outcome; Surgery

Indexed keywords

GASTRIN; HISTAMINE H2 RECEPTOR ANTAGONIST; OMEPRAZOLE; PANTOPRAZOLE; PROTON PUMP INHIBITOR; SECRETIN; SOMATOSTATIN RECEPTOR;

CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DELAYED DIAGNOSIS; DUODENOSTOMY; ENDOCRINE FUNCTION TEST; ENDOSCOPIC ECHOGRAPHY; ENDOSCOPIC SURGERY; GASTRINOMA; HUMAN; LABORATORY TEST; LAPAROSCOPIC SURGERY; LIVER METASTASIS; MULTIPLE ENDOCRINE NEOPLASIA; OUTCOME ASSESSMENT; PANCREATICODUODENECTOMY; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; REVIEW; SCINTIGRAPHY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STOMACH ACID HYPERSECRETION; STOMACH ACID SECRETION; STOMACH FUNCTION DISORDER; SURGICAL APPROACH; TOTAL STOMACH RESECTION; ZOLLINGER ELLISON SYNDROME;

DIAGNOSIS, DIFFERENTIAL; DIAGNOSTIC IMAGING; ENDOCRINE SURGICAL PROCEDURES; HUMANS; MULTIPLE ENDOCRINE NEOPLASIA TYPE 1; ZOLLINGER-ELLISON SYNDROME;

EID: 70349858259     PISSN: 00396109     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.suc.2009.06.018     Document Type: Review

References (63)

1. Zollinger R.M., and Ellison E.H. Primary peptic ulcerations of the jejunum associated with islet cell tumors of the pancreas. Ann Surg 142 4 (1955) 709-723 [discussion, 724-8]
2. Gibril F., and Jensen R.T. Zollinger-Ellison syndrome revisited: diagnosis, biologic markers, associated inherited disorders, and acid hypersecretion. Curr Gastroenterol Rep 6 6 (2004) 454-463
3. Peterson D.A., Dolan J.P., and Norton J.A. Neuroendocrine tumors of the pancreas and gastrointestinal tract and carcinoid disease. 2nd edition (2008), Springer, New York
4. Isenberg J.I., Walsh J.H., and Grossman M.I. Zollinger-Ellison syndrome. Gastroenterology 65 1 (1973) 140-165
5. Jensen R.T. Gastrinomas: advances in diagnosis and management. Neuroendocrinology 80 Suppl 1 (2004) 23-27
6. Roy P.K., Venzon D.J., Shojamanesh H., et al. Zollinger-Ellison syndrome. Clinical presentation in 261 patients. Medicine (Baltimore) 79 6 (2000) 379-411
7. Norton J.A. Gastrinoma: advances in localization and treatment. Surg Oncol Clin N Am 7 4 (1998) 845-861
8. Ellison E.C., and Johnson J.A. Current problems in surgery. The Zollinger-Ellison syndrome: a comprehensive review of historical, scientific, and clinical considerations. In brief. Curr Probl Surg 46 1 (2009) 6-11
9. Fendrich V., Langer P., Waldmann J., et al. Management of sporadic and multiple endocrine neoplasia type 1 gastrinomas. Br J Surg 94 11 (2007) 1331-1341
10. Cisco R.M., and Norton J.A. Surgery for gastrinoma. Adv Surg 41 (2007) 165-176
11. Corleto V.D., Annibale B., Gibril F., et al. Does the widespread use of proton pump inhibitors mask, complicate and/or delay the diagnosis of Zollinger-Ellison syndrome?. Aliment Pharmacol Ther 15 10 (2001) 1555-1561
12. Jensen R.T., and Fraker D.L. Zollinger-Ellison syndrome. Advances in treatment of gastric hypersecretion and the gastrinoma. JAMA 271 18 (1994) 1429-1435
13. Hoffmann K.M., Gibril F., Entsuah L.K., et al. Patients with multiple endocrine neoplasia type 1 with gastrinomas have an increased risk of severe esophageal disease including stricture and the premalignant condition, Barrett's esophagus. J Clin Endocrinol Metab 91 1 (2006) 204-212
14. Imamura M., Komoto I., and Ota S. Changing treatment strategy for gastrinoma in patients with Zollinger-Ellison syndrome. World J Surg 30 1 (2006) 1-11
15. Frucht H., Howard J.M., Slaff J.I., et al. Secretin and calcium provocative tests in the Zollinger-Ellison syndrome. A prospective study. Ann Intern Med 111 9 (1989) 713-722
16. Alexander H.R., Fraker D.L., Norton J.A., et al. Prospective study of somatostatin receptor scintigraphy and its effect on operative outcome in patients with Zollinger-Ellison syndrome. Ann Surg 228 2 (1998) 228-238
17. Gibril F., Reynolds J.C., Doppman J.L., et al. Somatostatin receptor scintigraphy: its sensitivity compared with that of other imaging methods in detecting primary and metastatic gastrinomas. A prospective study. Ann Intern Med 125 1 (1996) 26-34
18. Gibril F., and Jensen R.T. Diagnostic uses of radiolabelled somatostatin receptor analogues in gastroenteropancreatic endocrine tumours. Dig Liver Dis 36 Suppl 1 (2004) S106-S120
19. Gibril F., and Jensen R.T. Advances in evaluation and management of gastrinoma in patients with Zollinger-Ellison syndrome. Curr Gastroenterol Rep 7 2 (2005) 114-121
20. Termanini B., Gibril F., Reynolds J.C., et al. Value of somatostatin receptor scintigraphy: a prospective study in gastrinoma of its effect on clinical management. Gastroenterology 112 2 (1997) 335-347
21. Klose K.J., and Heverhagen J.T. Localisation and staging of gastrin producing tumours using cross-sectional imaging modalities. Wien Klin Wochenschr 119 19-20 (2007) 588-592
22. Fox P.S., Hofmann J.W., Decosse J.J., et al. The influence of total gastrectomy on survival in malignant Zollinger-Ellison tumors. Ann Surg 180 4 (1974) 558-566
23. McCarthy D.M. Report on the United States experience with cimetidine in Zollinger-Ellison syndrome and other hypersecretory states. Gastroenterology 74 2 Pt 2 (1978) 453-458
24. Stabile B.E., Morrow D.J., and Passaro Jr. E. The gastrinoma triangle: operative implications. Am J Surg 147 1 (1984) 25-31
25. Norton J.A., Alexander H.R., Fraker D.L., et al. Possible primary lymph node gastrinoma: occurrence, natural history, and predictive factors: a prospective study. Ann Surg 237 5 (2003) 650-657 [discussion: 657-9]
26. Norton J.A., Doppman J.L., and Jensen R.T. Curative resection in Zollinger-Ellison syndrome. Results of a 10-year prospective study. Ann Surg 215 1 (1992) 8-18
27. Sutliff V.E., Doppman J.L., Gibril F., et al. Growth of newly diagnosed, untreated metastatic gastrinomas and predictors of growth patterns. J Clin Oncol 15 6 (1997) 2420-2431
28. Norton J.A., Fraker D.L., Alexander H.R., et al. Surgery to cure the Zollinger-Ellison syndrome. N Engl J Med 341 9 (1999) 635-644
29. Doppman J.L. Pancreatic endocrine tumors-the search goes on. N Engl J Med 326 26 (1992) 1770-1772
30. Norton J.A., Cromack D.T., Shawker T.H., et al. Intraoperative ultrasonographic localization of islet cell tumors. A prospective comparison to palpation. Ann Surg 207 2 (1988) 160-168
31. Proye C., Pattou F., Carnaille B., et al. Intraoperative gastrin measurements during surgical management of patients with gastrinomas: experience with 20 cases. World J Surg 22 7 (1998) 643-649 [discussion: 649-50]
32. Norton J.A., Alexander H.R., Fraker D.L., et al. Does the use of routine duodenotomy (DUODX) affect rate of cure, development of liver metastases, or survival in patients with Zollinger-Ellison syndrome?. Ann Surg 239 5 (2004) 617-625 [discussion 626]
33. Norton J.A. Intraoperative methods to stage and localize pancreatic and duodenal tumors. Ann Oncol 10 Suppl 4 (1999) 182-184
34. Doherty G.M., and Thompson N.W. Multiple endocrine neoplasia type 1: duodenopancreatic tumours. J Intern Med 253 6 (2003) 590-598
35. Norton J.A., Fraker D.L., Alexander H.R., et al. Surgery increases survival in patients with gastrinoma. Ann Surg 244 3 (2006) 410-419
36. Norton J.A., and Jensen R.T. Resolved and unresolved controversies in the surgical management of patients with Zollinger-Ellison syndrome. Ann Surg 240 5 (2004) 757-773
37. Thompson N.W. Surgical treatment of the endocrine pancreas and Zollinger-Ellison syndrome in the MEN 1 syndrome. Henry Ford Hosp Med J 40 3-4 (1992) 195-198
38. Weber H.C., Orbuch M., and Jensen R.T. Diagnosis and management of Zollinger-Ellison syndrome. Semin Gastrointest Dis 6 2 (1995) 79-89
39. Fraker D.L., Norton J.A., Alexander H.R., et al. Surgery in Zollinger-Ellison syndrome alters the natural history of gastrinoma. Ann Surg 220 3 (1994) 320-328 [discussion: 328-30]
40. Norton J.A., Fang T.D., and Jensen R.T. Surgery for gastrinoma and insulinoma in multiple endocrine neoplasia type 1. J Natl Compr Canc Netw 4 2 (2006) 148-153
41. Norton J.A., Cornelius M.J., Doppman J.L., et al. Effect of parathyroidectomy in patients with hyperparathyroidism, Zollinger-Ellison syndrome, and multiple endocrine neoplasia type I: a prospective study. Surgery 102 6 (1987) 958-966
42. McArthur K.E., Richardson C.T., Barnett C.C., et al. Laparotomy and proximal gastric vagotomy in Zollinger-Ellison syndrome: results of a 16-year prospective study. Am J Gastroenterol 91 6 (1996) 1104-1111
43. Koop H., and Bachem M.G. Serum iron, ferritin, and vitamin B12 during prolonged omeprazole therapy. J Clin Gastroenterol 14 4 (1992) 288-292
44. Termanini B., Gibril F., Sutliff V.E., et al. Effect of long-term gastric acid suppressive therapy on serum vitamin B12 levels in patients with Zollinger-Ellison syndrome. Am J Med 104 5 (1998) 422-430
45. Weber H.C., Venzon D.J., Lin J.T., et al. Determinants of metastatic rate and survival in patients with Zollinger-Ellison syndrome: a prospective long-term study. Gastroenterology 108 6 (1995) 1637-1649
46. Ruszniewski P., and Malka D. Hepatic arterial chemoembolization in the management of advanced digestive endocrine tumors. Digestion 62 Suppl 1 (2000) 79-83
47. Ruszniewski P., Rougier P., Roche A., et al. Hepatic arterial chemoembolization in patients with liver metastases of endocrine tumors. A prospective phase II study in 24 patients. Cancer 71 8 (1993) 2624-2630
48. Delcore R., and Friesen S.R. Role of pancreatoduodenectomy in the management of primary duodenal wall gastrinomas in patients with Zollinger-Ellison syndrome. Surgery 112 6 (1992) 1016-1022 [discussion: 1022-33]
49. Imamura M., Kanda M., Takahashi K., et al. Clinicopathological characteristics of duodenal microgastrinomas. World J Surg 16 4 (1992) 703-709 [discussion: 709-10]
50. Stabile B.E., and Passaro Jr. E. Benign and malignant gastrinoma. Am J Surg 149 1 (1985) 144-150
51. Stadil F. Treatment of gastrinomas with pancreaticoduodenectomy. In: Mignon M., and Jensen R.T. (Eds). Frontiers in gastrointestinal research (1995), S. Karger, Basel, Switzerland
52. Tonelli F., Fratini G., Nesi G., et al. Pancreatectomy in multiple endocrine neoplasia type 1-related gastrinomas and pancreatic endocrine neoplasias. Ann Surg 244 1 (2006) 61-70
53. Pipeleers-Marichal M., Somers G., Willems G., et al. Gastrinomas in the duodenums of patients with multiple endocrine neoplasia type 1 and the Zollinger-Ellison syndrome. N Engl J Med 322 11 (1990) 723-727
54. Norton J.A. Surgical treatment and prognosis of gastrinoma. Best Pract Res Clin Gastroenterol 19 5 (2005) 799-805
55. Chen H., Hardacre J.M., Uzar A., et al. Isolated liver metastases from neuroendocrine tumors: does resection prolong survival?. J Am Coll Surg 187 1 (1998) 88-92 [discussion: 92-3].
56. Norton J.A., Doherty G.M., Fraker D.L., et al. Surgical treatment of localized gastrinoma within the liver: a prospective study. Surgery 124 6 (1998) 1145-1152
57. Sarmiento J.M., and Que F.G. Hepatic surgery for metastases from neuroendocrine tumors. Surg Oncol Clin N Am 12 1 (2003) 231-242
58. Assalia A., and Gagner M. Laparoscopic pancreatic surgery for islet cell tumors of the pancreas. World J Surg 28 12 (2004) 1239-1247
59. Pierce R.A., Spitler J.A., Hawkins W.G., et al. Outcomes analysis of laparoscopic resection of pancreatic neoplasms. Surg Endosc 21 4 (2007) 579-586
60. Straus E., Raufman J.P., Samuel S., et al. Endoscopic cure of the Zollinger-Ellison syndrome. Gastrointest Endosc 38 6 (1992) 709-711
61. Lee S.H., Hong Y.S., Lee J.M., et al. Duodenal gastrinoma treated with endoscopic band ligation. Gastrointest Endosc 69 4 (2009) 964-967
62. Thom A.K., Norton J.A., Axiotis C.A., et al. Location, incidence, and malignant potential of duodenal gastrinomas. Surgery 110 6 (1991) 1086-1091 [discussion: 1091-3]
63. Gibril F., and Jensen R.T. Comparative analysis of diagnostic techniques for localization of gastrointestinal neuroendocrine tumors. Yale J Biol Med 70 5-6 (1997) 509-522